MedTrace Logo

Efficacy Park Study Assessing Rhinix™ Nasal Filters for Hay Fever

NCT02108574 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2014-12-23

No results posted yet for this study

Summary

This study will evaluate the effects of RHINIX™ nasal filters on seasonal allergic rhinitis (hay fever) in a park setting.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DEVICE

Placebo Filter

DEVICE

Rhinix Nasal Filter

Sponsors & Collaborators

  • Rhinix ApS

    collaborator UNKNOWN

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Torben Sigsgaard, Professor · Aarhus University, School of Public Health, Dept. of Environmental & Occupational Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02108574 on ClinicalTrials.gov